2012–2013 Global Medical Devices Survey : Market Trends, Marketing Spend and Sales Strategies in the Global Medical Devices Industry

This survey helps analyze how medical devices industry companies’ media spend, marketing and sales strategies & practices and business planning are set to change in 2012–2013. This report provides the current size of the marketing and advertising budgets of global medical devices industry suppliers and how spending by global medical devices industry suppliers will change, providing insight into global marketing behaviour. In addition, the report also identifies future growth of buyers and suppliers and M&A activity. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and sizes.

Scope

• Project industry trends and revenue growth expectations in 2012 and understand business confidence to take informed business decisions.
• Drive revenues by understanding future product investment areas and key growth regions.
• Uncover key challenges and opportunities and identify key actions required to maintain and win buyer business.
• Formulate effective sales and marketing strategies by identifying how suppliers’ marketing budgets are changing and direction of spend in the future. Better promote your business by aligning your capabilities and business practices with your customer’s changing needs .
• Secure stronger customer relationships by understanding the behaviour and changing strategies of industry suppliers.

Global Medical Devices Industry

Published: March 2012

No. of Pages: 143
Price: Single User License: US$ 2000      Corporate User License: US$6000





Reasons To Buy

• Benchmarks sales and marketing plans with industry competitors to effectively determine strategy. This report also promotes your business by aligning your capabilities and business practices with your customers’ changing needs during these times of market uncertainty.
• This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report promotes your business by aligning your capabilities and business practices with your customer’s changing needs.
• The report is based on primary survey research conducted by ICD Research accessing its B2B panels comprised of senior purchase decision makers and leading supplier organizations.

Key Highlights

• ‘Customer retention’, ‘customer acquisition’, and ‘lead generation’ are identified as key marketing aims for global medical device industry suppliers by 77%, 54% and 31% of industry respondents respectively. In 2012, the key strategy that industry suppliers plan to employ is to ‘focus sales efforts on generating new business’, as identified by 53% of respondents.
• The ‘ability to target specific audience niches’, ‘flexibility in customizing services’ and ‘thorough reporting and analysis’ are considered chief success factors for marketing agencies. Survey results indicate that critical success factors have changed slightly since 2010 and 2011, and although the leading critical factor of the ‘ability to target specific audience niches’ remained in pole position throughout 2010–2012, the importance of ‘flexibility in customizing services’, and ‘thorough reporting and analysis’ has increased substantially in the recent survey.
• Across the industry, 61% of respondents are more optimistic about revenue growth for their company over the next 12 months.
• Of all respondents, 83% from the Rest of the World and 70% from Asia-Pacific are optimistic about revenue growth over the next 12 months, compared to 60% in North America and 53% in Europe.

Global Markets and Technologies for Home Medical Equipment

Since U.S. medical equipment manufacturers are among the largest suppliers to the global health care market, they need to gain the most detailed understanding of international markets for their products, including HME.

This report is intended to provide an objective, quantitative analysis that addresses the global market for HME in the context of technological change and an evolving market.  More specific objectives are to

• Identify and segment the main types of HME that have been commercialized to date.
• Analyze the historical and current value of shipments of each of these product segments in specified applications, end-user and geographical markets.
• Identify and evaluate the impact of demographic, technological, regulatory and other factors that will drive future demand in each of these segments.
• Forecast the value of future shipments in each segment.
• Identify promising new technologies and products still in the development and testing stage that are likely to be commercialized successfully in the next five years.
• Identify leading HME vendors.

INTENDED AUDIENCE
The report has been written for the entire medical and health care interest community, but it is tailored especially for readers with an interest in the marketing and management dimensions of home medical equipment, such as

• Manufacturers and distributors of HME.
• Regulators and health insurers.
• Investors.
• The financial and analyst community.

Home Medical Equipment Market

Published: March 2012
No. of Pages: 178
Price: Single User License: US$ 4850  Corporate User License: US$8500

 
  
This study was prepared using both primary and secondary research methodologies.  The findings and conclusions of this report are based on information gathered from manufacturers and distributors of HME, multilateral and government agencies, caregivers, insurance companies and other knowledgeable sources.   Interview data were combined with information gathered through an extensive review of secondary sources such as trade publications, trade associations, company literature and online databases to produce the baseline market estimates contained in this report.
The base year for analysis and projection is 2010.  With 2010 as a baseline, market projections were developed for 2011 to 2016.  These projections are based on a combination of a consensus among primary research sources and our understanding of key market drivers and their impact from a historical and analytical perspective.  The analytical methodologies used to generate the market estimates are described in detail in the section titled Detailed Market Projections.

ANAYST CREDENTIALS
The author of this report is Andrew McWilliams.  Mr. McWilliams is a partner in the Boston-based international technology and marketing consulting firm, 43rd Parallel LLC.  In addition to being the author of the previous (2007 and 2010) editions of this report, Mr. McWilliams  is the author of several other Business Communications Company studies of health care and related industries. These include HLC016D Microelectronic Medical Implants: Products, Technologies and Opportunities; HLC036D Medical Robotics and Computer-assisted Surgery: The Global Market;  HLC038C Patient Monitoring; HLC047C Disabled and Elderly Assistive Technologies; HLC051F The Market for Minimally Invasive Medical Devices; HLC070A Preventive Healthcare Technologies, Products and Markets; and AVM050B Smart and Interactive Textiles.

Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017

GlobalData’s new report, “Respiratory Measurement Devices Market Outlook in BRICS (Brazil, Russia, India, China, South Africa) to 2017” is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.

Respiratory Measurement Devices Market Outlook 

Published:January 2012
No. of Pages: 215

This report provides key market data on the Respiratory Measurement Devices market in the BRICS countries. The report provides value ($m), volume (units) and average price ($) data for each segment and sub-segment within three market categories – Pulse Oximeter Systems, Spirometers and Capnograph. The report also provides company shares and distribution shares data for the overall Respiratory Measurement Devices market in each of the aforementioned countries. The report is also supplemented with global corporate-level profiles of the key market participants with information on key developments, wherever available.
Scope

• Market size data for Respiratory Measurement Devices market categories – Pulse Oximeter Systems, Spirometers and Capnograph.
• Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the three market categories. Data from 2003 to 2010, forecast forward for seven years to 2017.
• 2010 company shares and distribution shares data for the overall Respiratory Measurement Devices market in each of the aforementioned countries.
• Global corporate-level profiles of key companies operating within the Respiratory Measurement Devices market in BRICS.
• Key players covered include Covidien plc, Draegerwerk AG & Co. KGaA, Masimo Corporation, Smiths Medical, Philips Respironics, Inc., GE Healthcare, CareFusion Corporation, Nonin Medical, Inc. and Invacare Corporation.

Reasons to buy

• Develop business strategies by identifying the key market categories and segments poised for strong growth.
• Develop market-entry and market expansion strategies.
• Design competition strategies by identifying who-stands-where in the Respiratory Measurement Devices competitive landscape in BRICS.
• Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
• What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017

Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017, a new report by Global Markets Direct, provides key market data on the Greece In Vitro Diagnostics market. The report provides value (USD million), for each segment and sub-segment within seven market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on key recent developments. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Global Markets Direct’s team of industry experts.

Greece In Vitro Diagnostics Investment Market

Published:January 2012
No. of Pages: 145

Scope

• Market size and company share data for In Vitro Diagnostics market categories – Clinical Chemistry, Genetic Testing, Haematology, Histology And Cytology, Immuno Chemistry, Infectious Immunology and Microbiology Culture.
• Annualized market revenues (USD million) for each of the segments and sub-segments within seven market categories. Data from 2003 to 2010, forecast forward for 7 years to 2017.
• 2010 company shares and distribution shares data for each of the seven market categories.
• Global corporate-level profiles of key companies operating within the Greece In Vitro Diagnosticsmarket.
• Key players covered include F. Hoffmann-La Roche Ltd., Siemens Healthcare, Abbott Laboratories, Beckman Coulter, Inc., Ortho-Clinical Diagnostics Inc., bioMerieux S.A. and others.

Reasons to Buy

Develop business strategies by identifying the key market categories and segments poised for strong growth.Develop market-entry and market expansion strategies.Design competition strategies by identifying who-stands-where in the Greece In Vitro Diagnostics competitive landscape.Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.